LIZORP SUSPENSION 250 mg/5 ml


Powder for suspension
scheduling status
S4
registration number
43/20.1.1/0536
What LIZORP SUSPENSION 250 mg/5 ml contains
Each 5 ml (after reconstitution) contains cefprozil monohydrate equivalent to 250 mg anhydrous cefprozil and sodium benzoate 0,064 % m/v as preservative. Contains sugar and sweetner: sucrose 2050,79 mg and 15 mg aspartame respectively per 5 mL reconstituted suspension.
other ingredients
The other ingredients of the formulation are sucrose, sodium chloride, citric acid monohydrate, simethicone emulsion, polysorbate 80, aspartame, glycine, carmellose sodium, microcrystalline cellulose/carboxymethylcellulose sodium, silica colloidal anhydrous, Bubble Gum Flavour (PWD # 730) and Colour FD&C Yellow No.6 (C.I. No: 15985).
Therapeutic classification
J01DC10.
© 2026 SAHPRA. ALL RIGHTS RESERVED